IBEX Limited Q4 2026 Earnings Call Summary
IBEX Limited reported strong financial performance in the fourth quarter of fiscal year 2026, achieving six consecutive quarters of double-digit revenue growth. The company surpassed its $100 million annual revenue target for HealthTech by reaching $114 million through organic expansion and partnerships with large payers and specialty providers. IBEX also formalized a strategic partnership with Sierra AI to deploy AI agents that improve resolution rates while maintaining high customer satisfaction levels. The firm is leveraging an employee net promoter score of 82 as a competitive advantage, linking strong engagement directly to operational outperformance. Management expects FY2027 revenue growth between 9% and 11%, supported by HealthTech momentum and AI deployment capabilities. Adjusted EBITDA margins are expected to expand in Q1 FY2027 after temporary pressures from new client costs. IBEX is shifting work toward high-margin offshore regions, where digital/omnichannel services now represent 82% of revenue. The company also renewed its credit facilities with HSBC and exited 'emerging growth' status as it initiates SOC certification for financial controls.
Tickers: $IBEX
Topics: ai_integration ebitda_forecast healthtech_expansion revenue_growth